• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

中国武汉 SARS-CoV-2 抗体血清阳性率。

Seropositive Prevalence of Antibodies Against SARS-CoV-2 in Wuhan, China.

机构信息

Experimental Medicine Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Health Management Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

出版信息

JAMA Netw Open. 2020 Oct 1;3(10):e2025717. doi: 10.1001/jamanetworkopen.2020.25717.

DOI:10.1001/jamanetworkopen.2020.25717
PMID:33095246
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7584925/
Abstract

This cross-sectional study examines the seropositive prevalence of antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Wuhan, China, by sex and age group.

摘要

本横断面研究按性别和年龄组检查了中国武汉 SARS-CoV-2 抗体血清阳性率。

相似文献

1
Seropositive Prevalence of Antibodies Against SARS-CoV-2 in Wuhan, China.中国武汉 SARS-CoV-2 抗体血清阳性率。
JAMA Netw Open. 2020 Oct 1;3(10):e2025717. doi: 10.1001/jamanetworkopen.2020.25717.
2
SARS-CoV-2 Does Not Replicate in Aedes Mosquito Cells nor Present in Field-Caught Mosquitoes from Wuhan.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）不在伊蚊细胞中复制，也不存在于从武汉采集的野外蚊子体内。
Virol Sin. 2020 Jun;35(3):355-358. doi: 10.1007/s12250-020-00251-0. Epub 2020 Jun 29.
3
The role of masks and respirator protection against SARS-CoV-2.口罩和呼吸器对严重急性呼吸综合征冠状病毒2的防护作用。
Infect Control Hosp Epidemiol. 2020 Jun;41(6):746-747. doi: 10.1017/ice.2020.83.
4
Emergence of SARS-like coronavirus in China: An update.中国出现类似严重急性呼吸综合征的冠状病毒：最新情况
J Infect. 2020 May;80(5):e28-e29. doi: 10.1016/j.jinf.2020.03.010. Epub 2020 Mar 13.
5
Neurological Manifestations of COVID-19: A systematic review and current update.新型冠状病毒肺炎的神经系统表现：系统评价和最新进展。
Acta Neurol Scand. 2020 Jul;142(1):14-22. doi: 10.1111/ane.13266. Epub 2020 Jun 2.
6
A cluster of pneumonia associated with the SARS-Cov-2 outside of Wuhan related to a house-warming banquet.武汉以外与一次乔迁宴相关的新冠肺炎聚集性病例。
J Infect. 2020 Jul;81(1):147-178. doi: 10.1016/j.jinf.2020.03.034. Epub 2020 Apr 10.
7
[Characteristics of SARS-CoV-2 and potential pharmacological treatment].[严重急性呼吸综合征冠状病毒2的特征及潜在药物治疗]
Postepy Biochem. 2020 May 9;66(2):83-90. doi: 10.18388/pb.2020_321.
8
Is Africa prepared for tackling the COVID-19 (SARS-CoV-2) epidemic. Lessons from past outbreaks, ongoing pan-African public health efforts, and implications for the future.非洲是否做好了应对新冠疫情（严重急性呼吸综合征冠状病毒2）的准备。从过去的疫情中吸取的教训、正在进行的泛非公共卫生努力以及对未来的影响。
Int J Infect Dis. 2020 Apr;93:233-236. doi: 10.1016/j.ijid.2020.02.049. Epub 2020 Feb 28.
9
The novel zoonotic COVID-19 pandemic: An expected global health concern.新型人畜共患的新冠疫情：一个意料之中的全球卫生问题。
J Infect Dev Ctries. 2020 Mar 31;14(3):254-264. doi: 10.3855/jidc.12671.
10
Large SARS-CoV-2 Outbreak Caused by Asymptomatic Traveler, China.中国无症状旅行者引发的大规模新冠病毒疫情。
Emerg Infect Dis. 2020 Dec;26(12):3106. doi: 10.3201/eid2612.203437.

引用本文的文献

1
Seroprevalence of SARS-CoV-2 Antibody Before and After Both Vaccination and Natural Infection in China.中国接种疫苗和自然感染前后SARS-CoV-2抗体的血清流行率
Immun Inflamm Dis. 2025 Mar;13(3):e70184. doi: 10.1002/iid3.70184.
2
Seroprevalence of SARS-CoV-2 in 10 Regional Capitals of Cameroon, October-December 2020.喀麦隆 10 个地区首府 2020 年 10 月至 12 月期间 SARS-CoV-2 的血清阳性率。
Influenza Other Respir Viruses. 2024 Apr;18(4):e13267. doi: 10.1111/irv.13267.
3
Levels of antibodies to SARS-CoV-2 at key time points during the COVID-19 pandemic in China.

本文引用的文献

1
Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections.无症状 SARS-CoV-2 感染的临床和免疫学评估。
Nat Med. 2020 Aug;26(8):1200-1204. doi: 10.1038/s41591-020-0965-6. Epub 2020 Jun 18.
2
Asymptomatic cases with SARS-CoV-2 infection.无症状的 SARS-CoV-2 感染病例。
J Med Virol. 2020 Sep;92(9):1401-1403. doi: 10.1002/jmv.25990. Epub 2020 May 22.
3
Antibody responses to SARS-CoV-2 in patients with COVID-19.新型冠状病毒肺炎（COVID-19）患者的 SARS-CoV-2 抗体反应。
中国新冠疫情期间关键时间点的新冠病毒抗体水平。
Front Public Health. 2023 Nov 22;11:1271917. doi: 10.3389/fpubh.2023.1271917. eCollection 2023.
4
The Transient IFN Response and the Delay of Adaptive Immunity Feature the Severity of COVID-19.瞬时 IFN 反应和适应性免疫的延迟是 COVID-19 严重程度的特征。
Front Immunol. 2022 Jan 14;12:816745. doi: 10.3389/fimmu.2021.816745. eCollection 2021.
5
The emergence, genomic diversity and global spread of SARS-CoV-2.SARS-CoV-2 的出现、基因组多样性和全球传播。
Nature. 2021 Dec;600(7889):408-418. doi: 10.1038/s41586-021-04188-6. Epub 2021 Dec 8.
6
Prevalence evolution of SARS-CoV-2 infection in the city of São Paulo, 2020-2021.2020-2021 年圣保罗市 SARS-CoV-2 感染的流行演变。
Rev Saude Publica. 2021 Oct 22;55:62. doi: 10.11606/s1518-8787.2021055003970. eCollection 2021.
7
Occurrence of COVID-19 Symptoms During SARS-CoV-2 Infection Defines Waning of Humoral Immunity.感染 SARS-CoV-2 期间出现 COVID-19 症状定义了体液免疫的衰减。
Front Immunol. 2021 Aug 16;12:722027. doi: 10.3389/fimmu.2021.722027. eCollection 2021.
8
SARS-CoV-2 Antibody Seroprevalence in Wuhan, China, from 23 April to 24 May 2020.2020 年 4 月 23 日至 5 月 24 日中国武汉 SARS-CoV-2 抗体血清阳性率。
mSphere. 2021 Apr 21;6(2):e01062-20. doi: 10.1128/mSphere.01062-20.
9
Seroprevalence and humoral immune durability of anti-SARS-CoV-2 antibodies in Wuhan, China: a longitudinal, population-level, cross-sectional study.血清阳性率和体液免疫对 SARS-CoV-2 抗体在中国武汉的持久性：一项纵向、人群水平、横断面研究。
Lancet. 2021 Mar 20;397(10279):1075-1084. doi: 10.1016/S0140-6736(21)00238-5.
10
Lessons learned 1 year after SARS-CoV-2 emergence leading to COVID-19 pandemic.SARS-CoV-2 引发 COVID-19 大流行一年后的经验教训。
Emerg Microbes Infect. 2021 Dec;10(1):507-535. doi: 10.1080/22221751.2021.1898291.
Nat Med. 2020 Jun;26(6):845-848. doi: 10.1038/s41591-020-0897-1. Epub 2020 Apr 29.
4
Detectable Serum Severe Acute Respiratory Syndrome Coronavirus 2 Viral Load (RNAemia) Is Closely Correlated With Drastically Elevated Interleukin 6 Level in Critically Ill Patients With Coronavirus Disease 2019.在重症 2019 冠状病毒病患者中，可检测到的血清严重急性呼吸综合征冠状病毒 2 病毒载量（RNAemia）与显著升高的白细胞介素 6 水平密切相关。
Clin Infect Dis. 2020 Nov 5;71(8):1937-1942. doi: 10.1093/cid/ciaa449.
5
Association of Public Health Interventions With the Epidemiology of the COVID-19 Outbreak in Wuhan, China.公共卫生干预措施与中国武汉 COVID-19 疫情流行病学的关联。
JAMA. 2020 May 19;323(19):1915-1923. doi: 10.1001/jama.2020.6130.
6
Covert coronavirus infections could be seeding new outbreaks.隐匿的新冠病毒感染可能正在引发新的疫情。
Nature. 2020 Mar 20. doi: 10.1038/d41586-020-00822-x.